．

Material Information - Argentina ANMAT has Approved the Marketing Authorization Application of BESREMi (Ropeginterferon alfa-2b) for PV

Jun 18, 2025

20250618 本公司新藥BESREMi獲阿根廷ANMAT核准使用於PV (EN).pdf

Download